EQT Fund Management S.a r.l.
An institutional investment manager in LUXEMBOURG. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 13, 2026. SEC CIK 1834239.
- Reported value$862.6m
- Positions5
Holdings: 5 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Waystar HLDG CorpWAY | COM | 946784105 | 511 | 59.2% | 24,879,437 | Unchanged | |
| Pharvaris N V | COM | N69605108 | 118 | 13.7% | 3,424,609 | Unchanged | |
| Oculis Holding AG | ORDINARY SHARES | H5870P102 | 96.4 | 11.2% | 6,950,294 | Added+1,050,000 | |
| Evommune IncEVMN | COM SHS | 30054Y107 | 70.3 | 8.1% | 5,288,313 | Added+358,680 | |
| Agomab Therapeutics NVAGMB | SPONSORED ADS | 00860C102 | 66.7 | 7.7% | 5,141,992 | Unchanged |
Source: SEC EDGAR, Form 13F-HR, accession 0001193125-26-349398 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.